Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INCORPORATED (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our Twin Momentum Investor model based on ...

Whether you’re a lingerie collector, Japanese denim nerd, or laundry procrastinator, you’ll need a reliable rack for clothing and textiles that need to air dry instead of going in the dryer ...

The most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $460, reflecting a -1.06% shift from the previouse trading day's closing. The stock trailed the S&P 500 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

福泰制药(VRTX) 在2024年的Jefferies工业会议上，高级副总裁Susie Lisa讨论了公司的当前状况和未来方向。她强调了公司在囊性纤维化（CF）治疗领域的 ...

In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price target of $431.00. The company’s shares ...

Joining us this morning at our Cantor Global Healthcare Conference. Really excited to have another year of it. My name is Olivia Brayer. I'm a senior Biotech Analyst here at Cantor. And we're ...

Vertex Pharmaceuticals (VRTX) closed at $489.43 in the latest trading session, marking a +0.84% move from the prior day. This move outpaced the S&P 500's daily gain of 0.13%. At the same time ...